Spikevax JN.1 Dosage/Direction for Use

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Dosage/Direction for Use

Posology: See Tables 3 and 4.

Click on icon to see table/diagram/image

Click on icon to see table/diagram/image

Paediatric population: Spikevax JN.1 dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine 50 micrograms/dose 0.5mL is not intended for children less than 12 years.
Elderly: No dose adjustment is required in elderly individuals ≥65 years of age.
Method of administration: The vaccine should be administered intramuscularly. The preferred site is the deltoid muscle of the upper arm.
Do not administer this vaccine intravascularly, subcutaneously or intradermally.
The vaccine should not be mixed in the same syringe with any other vaccines or medicinal products.
For precautions to be taken before administering the vaccine, see Precautions.
For instructions regarding thawing, handling and disposal of the vaccine, see Special precautions for disposal and other handling under Cautions for Usage.

Spikevax JN.1 Dosage/Direction for Use

Manufacturer:

Moderna

Distributor:

Zuellig